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 2 
Highlights 30 
• When matched for nitrate content both beetroot juice and chard gels, known to 31 
be rich in nitrate, increased plasma nitrate and nitrite concentrations and reduced 32 
blood pressure to a similar extent. 33 
• Inter-individual variability to reach maximal plasma nitrite levels was 34 
considerable and should be taken into account when utilizing acute dietary 35 
nitrate supplementation. 36 
• Plasma concentrations of total nitrosated products were higher with beetroot 37 
juice than with chard gel despite comparable nitrate content. 38 
 39 
Abstract 40 
Dietary supplementation with inorganic nitrate (NO3-) has been shown to induce a 41 
multitude of advantageous cardiovascular and metabolic responses during rest and 42 
exercise. While there is some suggestion that pharmacokinetics may differ depending 43 
on the NO3- source ingested, to the best of our knowledge this has yet to be determined 44 
experimentally. Here, we compare the plasma pharmacokinetics of NO3-, nitrite (NO2-45 
), and total nitroso species (RXNO) following oral ingestion of either NO3- rich beetroot 46 
juice (BR) or chard gels (GEL) with the associated changes in blood pressure (BP). 47 
Repeated samples of venous blood and measurements of BP were collected from nine 48 
healthy human volunteers before and after ingestion of the supplements using a cross-49 
over design. Plasma concentrations of RXNO and NO2- were quantified using reductive 50 
gas-phase chemiluminescence and NO3- using high pressure liquid ion chromatography. 51 
We report that, [NO3-] and [NO2-] were increased and systolic BP reduced to a similar 52 
extent in each experimental arm, with considerable inter-individual variation. 53 
Intriguingly, there was a greater increase in [RXNO] following ingestion of BR in 54 
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comparison to GEL, which may be a consequence of its higher polyphenol content. In 55 
conclusion, our data suggests that while differences in circulating NO2- and NO3- 56 
concentrations after oral administration of distinct NO3--rich supplementation sources 57 
are moderate, concentrations of metabolic by-products may show greater-than-58 
expected variability; the significance of the latter observation for the biological effects 59 
under study remains to be investigated.  60 
Key Words: nitrite, nitric oxide, dietary supplementation, blood pressure  61 
 62 
1. Introduction  63 
Dietary nitrate (NO3-) supplementation has been demonstrated to positively influence 64 
parameters of exercise performance (2, 25, 36) and vascular health (26, 27, 50, 54). 65 
These effects have been achieved utilizing a variety of different vehicles for NO3- 66 
delivery, including simple sodium (28) or potassium salts (23), NO3--rich foods (44), 67 
concentrated beetroot juice (BR) (58), and chard gel (GEL) (37, 38). These studies have 68 
consistently shown that circulating plasma [NO3-] and nitrite ([NO2-]) concentrations 69 
are increased following ingestion of NO3- supplements. Whilst the biological 70 
consequences of dietary NO3- administration are not fully understood at present, it is 71 
known that NO3- can be reduced to NO2-, which is believed to be subsequently further 72 
converted to bioactive nitric oxide (NO) (1, 31). The entero-salivary circulation plays 73 
a vital role in NO homeostasis with ∼25% of all circulating NO3- taken up by the 74 
salivary glands and concentrated in the saliva (51). The reduction of NO3- to NO2- takes 75 
place in the oral cavity where commensal facultative anaerobic bacteria on the surface 76 
of the tongue reduce NO3- to NO2- via NO3- reductase enzymes (12, 29). Once 77 
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swallowed, NO2- reaches the stomach where a proportion is then converted to NO, with 78 
the remainder being absorbed into circulation via the intestinal tract (3, 32, 33).  79 
It is well-established that increases in plasma [NO3-] and [NO2-] following dietary NO3- 80 
supplementation occur in a dose-dependent manner (4, 19, 21, 23, 58, 59), however the 81 
influence of the vehicle, if any, is less certain. Several studies have reported that plasma 82 
[NO3-] and [NO2-] -] reaches maximal quantities at ~ 1‒1.5 h and 2.5‒3h, respectively, 83 
after ingestion of BR (23, 35, 54, 58). Recent work from our laboratory has shown that 84 
consuming GEL results in similar plasma NO3- pharmacokinetics but plasma [NO2-] 85 
reaches maximal levels more quickly (~1.5 h) after ingestion (37). It is currently unclear 86 
whether the variance in NO2- pharmacokinetics between BR and GEL is simply due to 87 
the vehicle of administration or profoundly influenced by inter-cohort differences in 88 
the response to NO3- supplementation. Understanding if the vehicle of NO3- 89 
supplementation affects the fate of NO-related metabolites may allow for the 90 
optimization of dosing strategies for sports performance and other contexts.  Therefore, 91 
the purpose of this study was to compare the effects of ingesting BR and GEL on plasma 92 
NO metabolite pharmacokinetics and blood pressure (BP) pharmacodynamics in 93 
healthy individuals.  94 
 95 
2. Methods 96 
2.1 Participants 97 
Nine healthy adult males (age 28 ± 4 years, stature: 181 ± 8 cm, body mass: 83.4 ± 10.4 98 
kg) volunteered to take part in the study, which was approved by the School of Science 99 
and Sport Ethics Committee of the University of the West of Scotland. All participants 100 
provided written informed consent and a medical questionnaire before the study began. 101 
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Healthy males between the ages of 18 and 45 who were physically active (taking part 102 
in recreational activity a minimum of 3 times per week) were eligible to participate in 103 
the study. Participants were excluded if they were currently taking dietary supplements 104 
or any medication, regularly used mouthwash, were smokers, had a current illness or 105 
virus within the previous month, had a known disorder or history of disorders of the 106 
hematopoietic system, were hypertensive (≥140/90 mmHg) or had a family history of 107 
premature cardiovascular disease. All procedures were conducted in accordance with 108 
the Declaration of Helsinki. 109 
 110 
2.2 Experimental Design 111 
Our study had a simple randomized cross-over design. Participants visited the 112 
laboratory on two separate occasions with a minimum 7-day washout period and a 113 
maximum of 14 days between visits. Participants consumed either concentrated BR 114 
(Beet It Organic Shot, James White Drinks, Ipswich, UK) or GEL (Science in Sport, 115 
GO+ Nitrates, Lancashire, UK) during each trial. 116 
 117 
Participants were asked to refrain from the consumption of alcohol, caffeine, NO3- rich 118 
foods as outlined by Hord and colleagues (22), and to avoid any strenuous exercise for 119 
24 h before each trial. Participants were also asked to refrain from the use of anti-120 
bacterial mouthwash and chewing gum for the duration of the study as they have been 121 
shown to disturb the oral bacterial flora required for the conversion of NO3- to NO2- in 122 
the saliva (17, 41). Compliance to these factors was determined at the start of each visit. 123 
 124 
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Following a 12 h overnight fast, participants reported to the lab in the morning where 125 
they were asked to void the contents of their bladder and lie supine on a medical bed. 126 
After 15 min, BP was determined using an automated sphygmomanometer (Omron 127 
M10, Kyoto, Japan) three times, at 1 min intervals. A cannula was then inserted into 128 
the antecubital vein of the arm or a superficial vein on the dorsal surface of the hand 129 
and the line was kept patent by regular flushing with intravenous 0.9% saline solution. 130 
A sample of venous blood was then collected in a vacutainer containing EDTA and 131 
immediately centrifuged at 4000 rpm at 4oC for 10 min (Harrier 18/80, MSE, UK). The 132 
plasma was extracted carefully ensuring the cell layer was not disturbed and 133 
immediately frozen at -80oC for later analysis of plasma [NO3-], [NO2-], and total 134 
nitrosospecies [RXNO]. Participants then ingested either the BR or GEL supplements 135 
within 1 min of pre supplementation blood sampling.  The GEL supplement comprised 136 
120 ml of peach flavored sports gel containing 500 mg of NO3- from natural chard and 137 
rhubarb sources. In the BR trial, participants ingested 117 ml of concentrated BR that 138 
also contained 500 mg of NO3-. The NO3- content of the supplements was later verified 139 
using high-pressure liquid ion chromatography (section 2.3).   140 
 141 
As outlined in Fig. 1 venous blood samples were collected simultaneously with 142 
measurements of BP pre-supplementation then at 1, 1.5, 2, 2.5, 3, 3.5 and 6 h post-143 
ingestion of each supplement. The measurement of BP was carried out in triplicate, 144 
with the measurement being performed as close as possible to blood draw. The BP Cuff 145 
was placed on the opposite arm to the cannula. Participants remained supine from the 146 
first blood sample until the 3.5 h sample, after which they were allowed to sit at a desk, 147 
returning 30 min before the final sample. During the experimental trials, participants 148 
were provided with standardized meals, which had a low NO3- content. Specifically, 149 
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participants consumed a cereal bar after 1.5 h and a cheese sandwich 3.5 h after 150 
ingestion of BR or GEL. Participants were provided with ad libitum access to tap water.  151 
The volume consumed in trial 1 was recorded and kept consistent for trial 2.  152 
 153 
2.3 Additional Experimental Arm 154 
The aforementioned procedures were conducted to address the primary objective of this 155 
experiment whereby doses of GEL and BR matched for NO3- content were compared. 156 
Whereas the dose of GEL used in this experiment comprised two full gels as provided 157 
by the manufacturer (2 x 60g), 23 ml of BR was removed from one 70 ml bottle to 158 
ensure a matched NO3- content. Given that both researchers and end-users are more 159 
likely to utilize the full 140 ml (e.g. (21, 58) the dose of BR used in this experiment 160 
was considered to be lacking in ecological validity. To this end, eight of the participants 161 
completed an additional experimental trial where they received 140 ml of BR (600 mg 162 
of NO3-, H-BR) with the procedures repeated as previously described.  163 
 164 
2.4 Analysis of Plasma NO Metabolites 165 
High-pressure liquid ion chromatography was used to determine plasma [NO3-] and 166 
[NO2-]. Due to high variability in the NO2- measurements, which may relate to lack of 167 
specific sample processing without addition of N-ethylmaleimide prior to 168 
centrifugation, the NO2- data were re-analyzed using chemiluminescence and the latter 169 
was used in all calculations. Gas-phase chemiluminescence was used to determine 170 
plasma [RXNO].  Samples were thawed at room temperature in the presence of 5 mM 171 
N-ethylmaleimide and subsequently analyzed using an automated NOx detection 172 
system (Eicom, ENO-20, Kyoto, Japan, combined with a Gilson auto-sampler for [NO3-173 
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])(46) and a NO analyzer (Sievers NOA 280i, Analytix, UK for [NO2-] and CLD 77AM 174 
sp, ECOphysicis, Durnten, Switzerland for [RXNO]) in conjunction with a custom-175 
designed reaction chamber. NO2- levels were determined using 1% potassium iodide in 176 
5ml glacial acetic acid at room temperature for reduction of NO2- to NO (42); RXNO 177 
levels were determined using the triiodide method (13). All samples were analyzed 178 
within 3 months of sample collection in order to minimize degradation of NO 179 
metabolites.  180 
 181 
2.5 Data Analysis 182 
All analyses were carried out using the Statistical Package for the Social Sciences, 183 
Version 22 (SPSS Inc., Chicago, IL, USA) or GraphPad Prism version 6 (GraphPad 184 
Software Inc., San Diego, USA) for kinetic analyses. For brevity, data from the 185 
additional H-BR trial are not displayed in figures. The sample size was determined a 186 
priori using a power calculation which revealed that a minimum of eight participants 187 
was required to detect differences in the time taken for NO2- to peak between GEL and 188 
BR conditions. To establish the time to reach maximal [NO2-] and [NO3-] a log 189 
(Gaussian) non-linear regression model was applied to the data using the following 190 
equation: 191 
 Y=Amplitude*exp(-0.5*(ln(X/Center)/Width)^2). 192 
Data are expressed as the change in the mean (Δ) ± standard error of the mean (S.E.M) 193 
as compared to baseline or the mean and 95% confidence interval (CI) for time to reach 194 
maximal values. The distribution of the data was tested using the Shapiro-Wilk test. A 195 
two-way repeated-measures ANOVA was used to examine the differences between 196 
condition and over time for plasma NO3-, NO2-, RXNO, and BP. Post-hoc analysis to 197 
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determine the difference from the baseline was conducted using a paired samples t-tests 198 
with Bonferroni correction. Statistical significance was declared when P < 0.05.  199 
 200 
3. Results and Discussion 201 
Plasma [NO3-] and [NO2-] at baseline amounted to 26 ± 5.7 µM NO3=, 95 ± 31.9 nM 202 
NO2- for BR and 33 ± 3.4 µM NO3 -and 25 ± 6.7 nM NO2- for GEL. As expected, oral 203 
NO3- supplementation significantly increased plasma [NO3-] and [NO2-] in each 204 
experimental arm (P < 0.001) (Δ [NO3-] with BR: 319.4 ± 32.1 µM, with GEL: 383.9 205 
± 35.7 µM, Fig. 2; Δ [NO2-] with BR: 205.4 ± 51.9 nM, with GEL: 207.4 ± 58.1 nM, 206 
Fig. 3). The magnitude of the increase, however, was not different between BR and 207 
GEL (P > 0.10). In the H-BR arm, [NO2-] and [NO3-] increased to a greater extent than 208 
BR and GEL (Δ [NO2-] 277 ± 161 nM, Δ [NO3-] 457 ± 22 µM, both P < 0.01). 209 
Following ingestion of BR, [NO2-] reached maximal values at 3 h (95%CI 2.1 ‒ 3.9 h), 210 
which was not different to GEL (2.8 h, 95%CI 2.3 ‒ 3.2 h, P = 0.739). Likewise, the 211 
time taken for plasma [NO3-] to reach maximal concentrations was not different 212 
between BR and GEL (BR: 1.4 h 95%CI 0.8 ‒ 1.9 h, GEL: 1.4 h 95%CI 0.7 ‒ 2.1 h, P 213 
= 0.737). In the H-BR arm, [NO2-] and [NO3-] reached maximal concentration in the 214 
plasma after 3.2 h (95%CI 2.1 ‒ 4.2 h) and 1.5 h (95%CI 0.9 ‒ 2.1 h), respectively. 215 
These data collectively suggest that the vehicle of delivery, be it liquid or gel, does not 216 
impact the kinetics of the reduction of NO3- to NO2- or the maximal plasma 217 
concentrations of these metabolites. Nevertheless, it remains to be established whether 218 
NO3- supplementation in solid forms, such as whole vegetables or concentrated BR 219 
flapjacks, results in different NOx pharmacokinetics.  220 
 221 
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In the present study, plasma [NO2-] and [NO3-] reached maximal quantities within a 222 
similar timeframe to previous research with BR (19, 29, 40, 43). However, on this 223 
occasion [NO2-] took substantially longer after GEL (2.8 h) compared with our own 224 
previous work (1.5 h) (37). Given that descriptive and anthropometric variables were 225 
similar between the two study cohorts, it seems likely that physiological variations 226 
between individuals may account for these differences in time. Although plasma [NO2-227 
] is likely to be substantially elevated in most individuals 2.5 h after ingestion of either 228 
BR or GEL, the peak may reasonably occur anywhere between 2.1 and 3.9 h. To further 229 
highlight this Figure 4 displays the individual variability in the plasma NO2- response 230 
to both vehicles of supplementation. Another important factor to acknowledge when 231 
comparing different studies is the methods of analysis for NO metabolites. The 232 
sensitivity of chemiluminescence and HPLC has been highlighted with factors such as 233 
sample preparation, type of analyzer used, and duration of sample storage, all 234 
potentially influencing the result acquired (8, 42).  Whilst the precise mechanisms 235 
explaining the disparity in plasma [NO2-] pharmacokinetics between these studies are 236 
unclear, we speculate that this may at least be partially explained by variances in the 237 
gut microbiota (14), pH of oral cavity and stomach (18, 43), and differences in the 238 
composition of  the oral bacterial flora required for NO3- reduction (11, 18). The 239 
importance of the oral microbiome for NO3- reduction has been clearly established, with 240 
the oral reductase capacity substantially interrupted when using anti-bacterial 241 
mouthwash (5, 41, 55) or spitting of saliva following NO3- supplementation (30, 54). 242 
Equally, physical fitness has been suggested to affect the individual response to NO3- 243 
supplementation (18). In contrast to the direct association between endothelial NO 244 
production (as measured by plasma NO2-) and exercise performance (47, 53). Porcelli 245 
and colleagues (45) demonstrated that there was a negative association between aerobic 246 
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capacity (VO2peak) and the increase in plasma [NO2-] following ingestion of a NO3- 247 
supplement. Although not measured in either the present study or our previous work on 248 
NO3- pharmacokinetics (37), it is conceivable that individual differences in physical 249 
fitness, diet, or other lifestyle habits may contribute to the between-group variation 250 
reported here and elsewhere within the literature (18). Although it has not been 251 
thoroughly investigated, it is also conceivable that oral (and gut) microbial flora 252 
changes as a result of frequent NO3- supplementation. It has been recently demonstrated 253 
following 2 weeks of NO3- supplementation via BR there is an increase in salivary pH 254 
suggesting a role of NO3- supplementation in altering composition of the oral 255 
microbiome (20).   256 
 257 
Whilst the NO3- and NO2- responses were similar between experimental arms, an 258 
unexpected finding was that ingestion of BR tended to increase plasma [RXNO] to a 259 
greater extent in comparison to GEL (Δ in BR: 408.1 ± 127.9 nM vs. Δ in GEL: 148.1 260 
± 35.1 nM, P = 0.08, Fig. 5.). Plasma [RXNO] at baseline amounted to 79.5 ± 13.1 nM 261 
for BR and 71.9 ± 10.9 nM for GEL. There was, however, a high degree of variability 262 
in the change in [RXNO] between individuals and the small sample size likely explains 263 
why this finding was not statistically significant. The increase in [RXNO] was even 264 
greater in the H-BR trial (Δ563.8 ± 116.7 nM) at 2 h post ingestion than in GEL (P = 265 0.004) and BR (P=0.03). Although plasma [RXNO] is not measured routinely in NO3- 266 
supplementation studies, the magnitude by which [RXNO] increased following BR in 267 
the present study is greater than what has been previously reported [6]. Equally 268 
surprising was that the rise in [RXNO] exceeded that of [NO2-] following ingestion of 269 
BR. The explanation for this is presently uncertain and while differences in 270 
supplementation regimen, NO3- dose, and study participants may explain the disparity 271 
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with previous research, further work is required to explore the changes in [RXNO] and 272 
[NO2-] following ingestion of BR. 273 
 274 
What is also unclear is why ingestion of BR increases [RXNO] to a greater extent (at 275 
least in the H-BR trial) compared to GEL. Although care was taken to match the 276 
supplements for total NO3- content, differences in the polyphenol content between 277 
beetroot and chard may account for this outcome (24, 57). Furthermore, alongside the 278 
primary sources of NO3- the BR supplement contained additional ingredients including 279 
lemon juice and the GEL contained rhubarb juice, gelling agents, preservatives, and 280 
flavorings. While the total antioxidant and polyphenol content of BR has been defined 281 
(56, 57) there is no comparable data on GEL. The total polyphenol content of each 282 
supplement may be important for overall NO bioavailability. Ingestion of flavonoid 283 
rich apples, for example, has been shown to increase [RXNO] in healthy adults (6), and 284 
nitrated polyphenols are formed from acidified NO2- under simulated stomach 285 
conditions (40). Moreover, it has been shown that polyphenols augment the reduction 286 
of NO2- to NO in the gut (48, 49). Given that S-nitrosothiols (RSNO), a component of 287 
RXNO, act as a carrier and store of NO in the blood, a polyphenol-induced increase in 288 
the bioavailability of NO may reasonably be exhibited by an increase in total nitroso 289 
products following BR. The importance of the polyphenol content of NO3- supplements 290 
and the role of RXNO in the translation to consequent physiological outcomes has yet 291 
to be established. However, the high polyphenol content of BR (56, 57), may explain 292 
the greater reduction in oxygen consumption following BR compared to sodium NO3- 293 
(15). RXNOs are protected from direct NO scavenging by reactive oxygen species 294 
allowing NO to be transported by e.g. serum albumin and red blood cells (7, 52). This 295 
establishes an NO reservoir for the sustained release of NO from these biological 296 
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storage forms (9, 16, 34). Potentially allowing for the targeted delivery of NO to where 297 
it is required such as sites of ischemia during exercise.  298 
 299 
Systolic (SBP), diastolic (DBP), and mean arterial pressure (MAP) at baseline were as 300 
follows SBP: 123 ± 2 mmHg, DBP: 70 ± 1 mmHg, MAP: 88 ± 1 mmHg for BR and 301 
SBP: 124 ± 2 mmHg, DBP: 73 ± 2 mmHg, MAP: 90 ± 2 mmHg for GEL. In the present 302 
study, both BR and GEL reduced SBP and MAP (Δ SBP with BR: -10 ± 2 mmHg, P < 303 
0.001, vs. Baseline; with GEL: -12 ± 2 mmHg, P < 0.001; Δ MAP with BR: -5 ± 2 304 
mmHg, P = 0.012 vs Baseline; with GEL:  -7 ± 2 mmHg, P = 0.010, Fig. 6). The 305 
magnitude of the reductions in SBP and MAP were not different between BR and GEL 306 
(P ≥ 0.12). Neither GEL nor BR significantly altered DBP (P = 0.18) nor was there any 307 
difference between experimental arms (P = 0.197).  Likewise, SBP (Δ -11 ± 2 mmHg, 308 
P < 0.001) and MAP (Δ -8 ± 3 mmHg, P < 0.001) were reduced and DBP remained 309 
unchanged from baseline in the H-BR arm. It must be acknowledged that maintenance 310 
of the supine position for a prolonged period of time also likely contributed to a 311 
reduction in BP. Without a control condition, however, it is impossible to determine 312 
the extent of this effect. Nevertheless, these findings are consistent with previous 313 
literature demonstrating that ingestion of either BR or GEL reduces SBP and MAP 314 
among healthy individuals (23, 37, 54, 58). The response in DBP appears to be more 315 
variable, however, although several previous studies have reported comparable data (2, 316 
10, 23). Given the data presented here, it appears that the plasma [NO3-] and [NO2-] 317 
mirrors acute hemodynamic response to dietary NO3- closely. Of notable interest, 318 
however, is that the changes in [RXNO] did not appear to be associated with the 319 
magnitude of the reduction in BP. This is in contrast to work by Oplander and 320 
colleagues (39) who demonstrated that reductions in BP were associated with an 321 
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increased plasma availability of RXNO but not NO2- following exposure of the skin to 322 
ultraviolet radiation. It is conceivable, therefore, that the method by which NO 323 
bioavailability is augmented will alter the mechanisms by which BP is reduced.  324 
 325 
4. Conclusion 326 
Our data suggests that dietary NO3- supplementation via BR and GEL elicits similar 327 
plasma [NO2-] and [NO3-] pharmacokinetics when examined within the same participant 328 
cohort. Likewise, both BR and GEL are capable of reducing SBP and MAP with little 329 
difference in the magnitude of these effects. Nevertheless, we here present data 330 
demonstrating that the time course of ingesting the NO3- supplements to maximal [NO2-331 
] in blood plasma is profoundly variable between individuals. This is of major relevance 332 
for researchers wishing to determine the same. We also report, for the first time, that 333 
ingesting BR leads to a greater availability of RXNO compared to GEL, which we 334 
speculate may be attributed to the higher polyphenol content of the BR supplement.  335 
  336 
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Figure Captions 523 
 524 
Figure 1: Study overview: time-points for beetroot juice/chard gel administration, 525 
venous blood sampling, blood pressure measurements and food intake. 526 
Figure 2: Changes in plasma nitrate concentrations following supplementation with 527 
BR and GEL (Δ Mean ± S.E.M). * Significant difference from baseline (pre-528 
supplementation) (P < 0.001).  529 
Figure 3: Changes in plasma nitrite concentrations following supplementation with 530 
BR and GEL (Δ Mean ± S.E.M). * Significant difference from baseline (pre-531 
supplementation) 532 
Figure 4: Individual plasma nitrite pharmacokinetics and Systolic BP for BR and 533 
GEL. Each participant is represented by the same different colour in each figure.  534 
Figure 5: Changes in total nitroso species concentrations following supplementation 535 
with BR and GEL (Δ Mean ± S.E.M). * Significant difference from baseline (pre-536 
supplementation)  537 
Figure 6: Systolic (A), diastolic (B) and mean arterial pressure (C) changes following 538 
supplementation with BR and GEL  (Δ Mean ± S.E.M). * Significant difference from 539 
baseline (pre-supplementation) 540 
